- Home
- FVRR vs AVXL Comparison
FVRR vs AVXL Comparison
Compare FVRR & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FVRR
- AVXL
- Stock Information
- Founded
- FVRR 2010
- AVXL 2004
- Country
- FVRR Israel
- AVXL United States
- Employees
- FVRR N/A
- AVXL N/A
- Industry
- FVRR Business Services
- AVXL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FVRR Consumer Discretionary
- AVXL Health Care
- Exchange
- FVRR Nasdaq
- AVXL Nasdaq
- Market Cap
- FVRR 1.0B
- AVXL 956.7M
- IPO Year
- FVRR 2019
- AVXL N/A
- Fundamental
- Price
- FVRR $24.37
- AVXL $8.78
- Analyst Decision
- FVRR Buy
- AVXL Strong Buy
- Analyst Count
- FVRR 11
- AVXL 2
- Target Price
- FVRR $33.10
- AVXL $44.00
- AVG Volume (30 Days)
- FVRR 603.3K
- AVXL 944.5K
- Earning Date
- FVRR 10-29-2025
- AVXL 08-12-2025
- Dividend Yield
- FVRR N/A
- AVXL N/A
- EPS Growth
- FVRR 70.84
- AVXL N/A
- EPS
- FVRR 0.50
- AVXL N/A
- Revenue
- FVRR $419,126,000.00
- AVXL N/A
- Revenue This Year
- FVRR $13.15
- AVXL N/A
- Revenue Next Year
- FVRR $8.00
- AVXL N/A
- P/E Ratio
- FVRR $46.81
- AVXL N/A
- Revenue Growth
- FVRR 12.60
- AVXL N/A
- 52 Week Low
- FVRR $20.83
- AVXL $5.03
- 52 Week High
- FVRR $36.11
- AVXL $14.44
- Technical
- Relative Strength Index (RSI)
- FVRR 56.16
- AVXL 39.78
- Support Level
- FVRR $22.10
- AVXL $8.85
- Resistance Level
- FVRR $24.40
- AVXL $9.69
- Average True Range (ATR)
- FVRR 0.84
- AVXL 0.55
- MACD
- FVRR 0.12
- AVXL -0.02
- Stochastic Oscillator
- FVRR 89.37
- AVXL 1.82
About FVRR Fiverr International Ltd. no par value
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Wiring and Translation, and Video and Animation among others.
About AVXL Anavex Life Sciences Corp.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.